REAL WORLD EVIDENCE NEEDS IN ONCOLOGY: Melanoma
White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid.
Advancements in melanoma therapies presented at ESMO 2023 mark a shift, where the integration of innovative treatments with real-world data is paving the way for more personalized and effective care in melanoma.
In this white paper we summarise the key findings from completed and ongoing clinical studies of melanoma that were presented at ESMO, synthesizing the insights from the conference and integrating them with established ESMO oncology RWE guidelines and protocols.
To download the white paper please complete the following form: